SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-performance target ...
Agilent Technologies A made an announcement to take over an early-stage life sciences company, Avida Biomed. Avida Biomed develops high-performance target enrichment workflows to aid clinical ...
SALT LAKE CITY, Dec. 19, 2025 /PRNewswire/ -- Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent ...
Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results